nieuws



Compounds fend off Alzheimer's disease amyloid pathology

 

A team of scientists, led by University of California, San Diego School of Medicine researchers, has synthesized hundreds of new compounds with the potential of reducing the production of the A-beta 42 peptide, a primary component of Alzheimer's disease.

Link


[ Terug naar het hoofdmenu ]